Personalized Cancer Treatment Planning
An oncologist treating a patient with non-small cell lung cancer uses a precision medicine platform to analyze the tumor's genomic sequencing data. The AI identifies a specific EGFR mutation that is known to respond well to a targeted therapy. Instead of prescribing standard chemotherapy, the platform recommends a specific EGFR inhibitor. This allows the oncologist to choose a more effective treatment with potentially fewer side effects, personalizing the care plan directly to the patient's tumor biology and improving the chances of a positive outcome.
